6-43523209-T-G

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_020750.3(XPO5):c.*659A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The gene XPO5 is a tumor suppressor gene (CancerMine: 1 TSG, 1 oncogene citations). The gene XPO5 is a known oncogene (CancerMine: 1 TSG, 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.456 (AC=78,039) in the gnomAD database across 170,988 control chromosomes, including 19,258 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.624. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 17667 hom., cov: 32)
Exomes 𝑓: 0.38 ( 1591 hom. )

Consequence

XPO5
NM_020750.3 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.233

Publications

5 publications found
Variant links:
Genes affected
XPO5 (HGNC:17675): (exportin 5) This gene encodes a member of the karyopherin family that is required for the transport of small RNAs and double-stranded RNA-binding proteins from the nucleus to the cytoplasm. The encoded protein translocates cargo through the nuclear pore complex in a RanGTP-dependent process. [provided by RefSeq, Aug 2011]
XPO5 Gene-Disease associations (from GenCC):
  • nephrotic syndrome
    Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia
POLR1C (HGNC:20194): (RNA polymerase I and III subunit C) The protein encoded by this gene is a subunit of both RNA polymerase I and RNA polymerase III complexes. The encoded protein is part of the Pol core element. Mutations in this gene have been associated with Treacher Collins syndrome (TCS) and hypomyelinating leukodystrophy 11. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
POLR1C Gene-Disease associations (from GenCC):
  • POLR1C-related disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • leukodystrophy, hypomyelinating, 11
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • Treacher Collins syndrome 3
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • Treacher-Collins syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020750.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.624 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_020750.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

XPO5 NM_020750.3
MANE Select
HGVSc / HGVSpc.*659A>C
Exon rankExon 32 of 32
3_prime_UTR
Prot: NP_065801.1UniProt: Q9HAV4
POLR1C NM_001318876.2
HGVSc / HGVSpc.922+2161T>G
Exon rankIntron 8 of 8
intron
Prot: NP_001305805.1UniProt: O15160-2
POLR1C NM_001363658.2
HGVSc / HGVSpc.922+2161T>G
Exon rankIntron 8 of 9
intron
Prot: NP_001350587.1UniProt: A0A2R8YEZ4

Ensembl Transcripts

XPO5 ENST00000265351.12
TSL:1MANE Select
HGVSc / HGVSpc.*659A>C
Exon rankExon 32 of 32
3_prime_UTR
Prot: ENSP00000265351.7UniProt: Q9HAV4
POLR1C ENST00000304004.7
TSL:1
HGVSc / HGVSpc.922+2161T>G
Exon rankIntron 8 of 8
intron
Prot: ENSP00000307212.3UniProt: O15160-2
XPO5 ENST00000943409.1
HGVSc / HGVSpc.*659A>C
Exon rankExon 32 of 32
3_prime_UTR
Prot: ENSP00000613468.1UniProt: A0ACI8U9B7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.465
AC:70693
Hom:17637
AN:151938
Cov:32
GnomAD4 exome
AF: 0.383
AC:7256
Hom:1591
AN:18932
Cov:0
GnomAD4 genome
AF: 0.466
AC:70783
Hom:17667
AN:152056
Cov:32
TOPMed (Bravo)
AF: 0.470
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.441
AC:92246
Hom:20886
AN:209136
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.470
AC:1100
Hom:291
AN:2342
ChinaMAP Phase 1
AF: 0.0738
Denmark Genome
AF: 0.407
AC:122
AN:300
GenomeAsia100K
AF: 0.263
AC:917
AN:3478
Korea4K (4,157 Koreans)
AF: 0.0780
AC:564
AN:7234
Qatari Genome
AF: 0.386
AC:68
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0684
AC:8396
Hom:287
AN:122670
Turkish Variome
AF: 0.396
AC:612
Hom:113
AN:1546
UK10K
AF: 0.425
AC:3216
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0670
AC:600
Hom:23
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.255 602023630 0.129 394730642
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign3.1
BayesDel_noAF
Benign-0.72
CADD
Benign2.7
DANN
Benign0.78
GPN-Star LLR
N/A6.8
GPN-Star score
N/A2.0
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-0.23
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.